The Red Biotechnology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Red Biotechnology market size is estimated to be worth US$ 283350 million in 2021 and is forecast to a readjusted size of USD 354530 million by 2028 with a CAGR of 3.3% during review period. Biopharmaceutical Production accounting for % of the Red Biotechnology global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Antibody segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Red Biotechnology include F. Hoffmann-La Roche, Amgen, Gilead Sciences, CSL, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Red Biotechnology market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antibody
Nucleic Acid
Protein
Other
Market segment by Application, can be divided into
Biopharmaceutical Production
Gene Therapy
Pharmacogenomics and Genetic Testing
Market segment by players, this report covers
F. Hoffmann-La Roche
Amgen
Gilead Sciences
CSL
Pfizer
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Red Biotechnology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Red Biotechnology, with revenue, gross margin and global market share of Red Biotechnology from 2019 to 2022.
Chapter 3, the Red Biotechnology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Red Biotechnology market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Red Biotechnology research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Red Biotechnology
1.2 Classification of Red Biotechnology by Type
1.2.1 Overview: Global Red Biotechnology Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Red Biotechnology Revenue Market Share by Type in 2021
1.2.3 Antibody
1.2.4 Nucleic Acid
1.2.5 Protein
1.2.6 Other
1.3 Global Red Biotechnology Market by Application
1.3.1 Overview: Global Red Biotechnology Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Biopharmaceutical Production
1.3.3 Gene Therapy
1.3.4 Pharmacogenomics and Genetic Testing
1.4 Global Red Biotechnology Market Size & Forecast
1.5 Global Red Biotechnology Market Size and Forecast by Region
1.5.1 Global Red Biotechnology Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Red Biotechnology Market Size by Region, (2017-2022)
1.5.3 North America Red Biotechnology Market Size and Prospect (2017-2028)
1.5.4 Europe Red Biotechnology Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Red Biotechnology Market Size and Prospect (2017-2028)
1.5.6 South America Red Biotechnology Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Red Biotechnology Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Red Biotechnology Market Drivers
1.6.2 Red Biotechnology Market Restraints
1.6.3 Red Biotechnology Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business
2.1.3 F. Hoffmann-La Roche Red Biotechnology Product and Solutions
2.1.4 F. Hoffmann-La Roche Red Biotechnology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Red Biotechnology Product and Solutions
2.2.4 Amgen Red Biotechnology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Amgen Recent Developments and Future Plans
2.3 Gilead Sciences
2.3.1 Gilead Sciences Details
2.3.2 Gilead Sciences Major Business
2.3.3 Gilead Sciences Red Biotechnology Product and Solutions
2.3.4 Gilead Sciences Red Biotechnology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Gilead Sciences Recent Developments and Future Plans
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business
2.4.3 CSL Red Biotechnology Product and Solutions
2.4.4 CSL Red Biotechnology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 CSL Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Red Biotechnology Product and Solutions
2.5.4 Pfizer Red Biotechnology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Pfizer Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Red Biotechnology Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Red Biotechnology Players Market Share in 2021
3.2.2 Top 10 Red Biotechnology Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Red Biotechnology Players Head Office, Products and Services Provided
3.4 Red Biotechnology Mergers & Acquisitions
3.5 Red Biotechnology New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Red Biotechnology Revenue and Market Share by Type (2017-2022)
4.2 Global Red Biotechnology Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Red Biotechnology Revenue Market Share by Application (2017-2022)
5.2 Global Red Biotechnology Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Red Biotechnology Revenue by Type (2017-2028)
6.2 North America Red Biotechnology Revenue by Application (2017-2028)
6.3 North America Red Biotechnology Market Size by Country
6.3.1 North America Red Biotechnology Revenue by Country (2017-2028)
6.3.2 United States Red Biotechnology Market Size and Forecast (2017-2028)
6.3.3 Canada Red Biotechnology Market Size and Forecast (2017-2028)
6.3.4 Mexico Red Biotechnology Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Red Biotechnology Revenue by Type (2017-2028)
7.2 Europe Red Biotechnology Revenue by Application (2017-2028)
7.3 Europe Red Biotechnology Market Size by Country
7.3.1 Europe Red Biotechnology Revenue by Country (2017-2028)
7.3.2 Germany Red Biotechnology Market Size and Forecast (2017-2028)
7.3.3 France Red Biotechnology Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Red Biotechnology Market Size and Forecast (2017-2028)
7.3.5 Russia Red Biotechnology Market Size and Forecast (2017-2028)
7.3.6 Italy Red Biotechnology Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Red Biotechnology Revenue by Type (2017-2028)
8.2 Asia-Pacific Red Biotechnology Revenue by Application (2017-2028)
8.3 Asia-Pacific Red Biotechnology Market Size by Region
8.3.1 Asia-Pacific Red Biotechnology Revenue by Region (2017-2028)
8.3.2 China Red Biotechnology Market Size and Forecast (2017-2028)
8.3.3 Japan Red Biotechnology Market Size and Forecast (2017-2028)
8.3.4 South Korea Red Biotechnology Market Size and Forecast (2017-2028)
8.3.5 India Red Biotechnology Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Red Biotechnology Market Size and Forecast (2017-2028)
8.3.7 Australia Red Biotechnology Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Red Biotechnology Revenue by Type (2017-2028)
9.2 South America Red Biotechnology Revenue by Application (2017-2028)
9.3 South America Red Biotechnology Market Size by Country
9.3.1 South America Red Biotechnology Revenue by Country (2017-2028)
9.3.2 Brazil Red Biotechnology Market Size and Forecast (2017-2028)
9.3.3 Argentina Red Biotechnology Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Red Biotechnology Revenue by Type (2017-2028)
10.2 Middle East & Africa Red Biotechnology Revenue by Application (2017-2028)
10.3 Middle East & Africa Red Biotechnology Market Size by Country
10.3.1 Middle East & Africa Red Biotechnology Revenue by Country (2017-2028)
10.3.2 Turkey Red Biotechnology Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Red Biotechnology Market Size and Forecast (2017-2028)
10.3.4 UAE Red Biotechnology Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Red Biotechnology Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Red Biotechnology Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Red Biotechnology Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Red Biotechnology Revenue (USD Million) by Region (2017-2022)
Table 5. Global Red Biotechnology Revenue Market Share by Region (2023-2028)
Table 6. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 7. F. Hoffmann-La Roche Major Business
Table 8. F. Hoffmann-La Roche Red Biotechnology Product and Solutions
Table 9. F. Hoffmann-La Roche Red Biotechnology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Amgen Corporate Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Red Biotechnology Product and Solutions
Table 13. Amgen Red Biotechnology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 15. Gilead Sciences Major Business
Table 16. Gilead Sciences Red Biotechnology Product and Solutions
Table 17. Gilead Sciences Red Biotechnology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. CSL Corporate Information, Head Office, and Major Competitors
Table 19. CSL Major Business
Table 20. CSL Red Biotechnology Product and Solutions
Table 21. CSL Red Biotechnology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer Red Biotechnology Product and Solutions
Table 25. Pfizer Red Biotechnology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Global Red Biotechnology Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 27. Global Red Biotechnology Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 28. Breakdown of Red Biotechnology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Red Biotechnology Players Head Office, Products and Services Provided
Table 30. Red Biotechnology Mergers & Acquisitions in the Past Five Years
Table 31. Red Biotechnology New Entrants and Expansion Plans
Table 32. Global Red Biotechnology Revenue (USD Million) by Type (2017-2022)
Table 33. Global Red Biotechnology Revenue Share by Type (2017-2022)
Table 34. Global Red Biotechnology Revenue Forecast by Type (2023-2028)
Table 35. Global Red Biotechnology Revenue by Application (2017-2022)
Table 36. Global Red Biotechnology Revenue Forecast by Application (2023-2028)
Table 37. North America Red Biotechnology Revenue by Type (2017-2022) & (USD Million)
Table 38. North America Red Biotechnology Revenue by Type (2023-2028) & (USD Million)
Table 39. North America Red Biotechnology Revenue by Application (2017-2022) & (USD Million)
Table 40. North America Red Biotechnology Revenue by Application (2023-2028) & (USD Million)
Table 41. North America Red Biotechnology Revenue by Country (2017-2022) & (USD Million)
Table 42. North America Red Biotechnology Revenue by Country (2023-2028) & (USD Million)
Table 43. Europe Red Biotechnology Revenue by Type (2017-2022) & (USD Million)
Table 44. Europe Red Biotechnology Revenue by Type (2023-2028) & (USD Million)
Table 45. Europe Red Biotechnology Revenue by Application (2017-2022) & (USD Million)
Table 46. Europe Red Biotechnology Revenue by Application (2023-2028) & (USD Million)
Table 47. Europe Red Biotechnology Revenue by Country (2017-2022) & (USD Million)
Table 48. Europe Red Biotechnology Revenue by Country (2023-2028) & (USD Million)
Table 49. Asia-Pacific Red Biotechnology Revenue by Type (2017-2022) & (USD Million)
Table 50. Asia-Pacific Red Biotechnology Revenue by Type (2023-2028) & (USD Million)
Table 51. Asia-Pacific Red Biotechnology Revenue by Application (2017-2022) & (USD Million)
Table 52. Asia-Pacific Red Biotechnology Revenue by Application (2023-2028) & (USD Million)
Table 53. Asia-Pacific Red Biotechnology Revenue by Region (2017-2022) & (USD Million)
Table 54. Asia-Pacific Red Biotechnology Revenue by Region (2023-2028) & (USD Million)
Table 55. South America Red Biotechnology Revenue by Type (2017-2022) & (USD Million)
Table 56. South America Red Biotechnology Revenue by Type (2023-2028) & (USD Million)
Table 57. South America Red Biotechnology Revenue by Application (2017-2022) & (USD Million)
Table 58. South America Red Biotechnology Revenue by Application (2023-2028) & (USD Million)
Table 59. South America Red Biotechnology Revenue by Country (2017-2022) & (USD Million)
Table 60. South America Red Biotechnology Revenue by Country (2023-2028) & (USD Million)
Table 61. Middle East & Africa Red Biotechnology Revenue by Type (2017-2022) & (USD Million)
Table 62. Middle East & Africa Red Biotechnology Revenue by Type (2023-2028) & (USD Million)
Table 63. Middle East & Africa Red Biotechnology Revenue by Application (2017-2022) & (USD Million)
Table 64. Middle East & Africa Red Biotechnology Revenue by Application (2023-2028) & (USD Million)
Table 65. Middle East & Africa Red Biotechnology Revenue by Country (2017-2022) & (USD Million)
Table 66. Middle East & Africa Red Biotechnology Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Red Biotechnology Picture
Figure 2. Global Red Biotechnology Revenue Market Share by Type in 2021
Figure 3. Antibody
Figure 4. Nucleic Acid
Figure 5. Protein
Figure 6. Other
Figure 7. Red Biotechnology Revenue Market Share by Application in 2021
Figure 8. Biopharmaceutical Production Picture
Figure 9. Gene Therapy Picture
Figure 10. Pharmacogenomics and Genetic Testing Picture
Figure 11. Global Red Biotechnology Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Red Biotechnology Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Red Biotechnology Revenue Market Share by Region (2017-2028)
Figure 14. Global Red Biotechnology Revenue Market Share by Region in 2021
Figure 15. North America Red Biotechnology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Red Biotechnology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Red Biotechnology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Red Biotechnology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Red Biotechnology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Red Biotechnology Market Drivers
Figure 21. Red Biotechnology Market Restraints
Figure 22. Red Biotechnology Market Trends
Figure 23. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 24. Amgen Recent Developments and Future Plans
Figure 25. Gilead Sciences Recent Developments and Future Plans
Figure 26. CSL Recent Developments and Future Plans
Figure 27. Pfizer Recent Developments and Future Plans
Figure 28. Global Red Biotechnology Revenue Share by Players in 2021
Figure 29. Red Biotechnology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 30. Global Top 3 Players Red Biotechnology Revenue Market Share in 2021
Figure 31. Global Top 10 Players Red Biotechnology Revenue Market Share in 2021
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 33. Global Red Biotechnology Revenue Share by Type in 2021
Figure 34. Global Red Biotechnology Market Share Forecast by Type (2023-2028)
Figure 35. Global Red Biotechnology Revenue Share by Application in 2021
Figure 36. Global Red Biotechnology Market Share Forecast by Application (2023-2028)
Figure 37. North America Red Biotechnology Sales Market Share by Type (2017-2028)
Figure 38. North America Red Biotechnology Sales Market Share by Application (2017-2028)
Figure 39. North America Red Biotechnology Revenue Market Share by Country (2017-2028)
Figure 40. United States Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Red Biotechnology Sales Market Share by Type (2017-2028)
Figure 44. Europe Red Biotechnology Sales Market Share by Application (2017-2028)
Figure 45. Europe Red Biotechnology Revenue Market Share by Country (2017-2028)
Figure 46. Germany Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Red Biotechnology Sales Market Share by Type (2017-2028)
Figure 52. Asia-Pacific Red Biotechnology Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Red Biotechnology Revenue Market Share by Region (2017-2028)
Figure 54. China Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Japan Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. South Korea Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. India Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Southeast Asia Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Australia Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South America Red Biotechnology Sales Market Share by Type (2017-2028)
Figure 61. South America Red Biotechnology Sales Market Share by Application (2017-2028)
Figure 62. South America Red Biotechnology Revenue Market Share by Country (2017-2028)
Figure 63. Brazil Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Argentina Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Middle East and Africa Red Biotechnology Sales Market Share by Type (2017-2028)
Figure 66. Middle East and Africa Red Biotechnology Sales Market Share by Application (2017-2028)
Figure 67. Middle East and Africa Red Biotechnology Revenue Market Share by Country (2017-2028)
Figure 68. Turkey Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Saudi Arabia Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. UAE Red Biotechnology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source